Reply to Verweij et al

Timothy M. Uyeki; Michael G. Ison; Cameron R. Wolfe; Andrew T. Pavia

doi:10.1093/cid/ciz568

Reply to Verweij et al

Timothy M. Uyeki, Michael G. Ison, Cameron R. Wolfe, Andrew T. Pavia

Medicine, Infectious Diseases Division

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	350-351
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	70
Issue number	2
DOIs	https://doi.org/10.1093/cid/ciz568
State	Published - Jan 15 2020

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciz568

Cite this

@article{4ed6f0d5998340449056ee3c670cdee6,

title = "Reply to Verweij et al",

author = "Uyeki, {Timothy M.} and Ison, {Michael G.} and Wolfe, {Cameron R.} and Pavia, {Andrew T.}",

note = "Funding Information: Potential conflicts of interest. M. G. I. reports grants from Emergent BioScience, grants and travel support from Genentech/Roche, grants and personal fees from Janssen, and personal fees from Celltrion, Shionogi, and VirBio during the conduct of the study. M. G. I. also reports grants from AiCuris, Chimerix, and Gilead and personal fees from Viracor Eurofins outside the submitted work. A. T. P. reports grants from BioFire Diagnostics, royalties from Antimicrobial Therapy Inc as associate editor of Sanford Guide, personal fees from WebMD for the preparation of educational materials, and personal fees as a consultant for Genentech, outside the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.",

year = "2020",

month = jan,

day = "15",

doi = "10.1093/cid/ciz568",

language = "English (US)",

volume = "70",

pages = "350--351",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Reply to Verweij et al

AU - Uyeki, Timothy M.

AU - Ison, Michael G.

AU - Wolfe, Cameron R.

AU - Pavia, Andrew T.

N1 - Funding Information: Potential conflicts of interest. M. G. I. reports grants from Emergent BioScience, grants and travel support from Genentech/Roche, grants and personal fees from Janssen, and personal fees from Celltrion, Shionogi, and VirBio during the conduct of the study. M. G. I. also reports grants from AiCuris, Chimerix, and Gilead and personal fees from Viracor Eurofins outside the submitted work. A. T. P. reports grants from BioFire Diagnostics, royalties from Antimicrobial Therapy Inc as associate editor of Sanford Guide, personal fees from WebMD for the preparation of educational materials, and personal fees as a consultant for Genentech, outside the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

PY - 2020/1/15

Y1 - 2020/1/15

UR - http://www.scopus.com/inward/record.url?scp=85077380279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077380279&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz568

DO - 10.1093/cid/ciz568

M3 - Letter

C2 - 31894248

AN - SCOPUS:85077380279

SN - 1058-4838

VL - 70

SP - 350

EP - 351

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Reply to Verweij et al

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this